NCT07096830View on ClinicalTrials.gov

Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing

NANot yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

August 30, 2026

Conditions
Chronic Wound Care
Interventions
DRUG

Topical Tetrachlorodecaoxide (TCDO/Oxoferin)

Topical Tetrachlorodecaoxide (TCDO), a solution with antimicrobial and oxygen-releasing properties, will be applied once daily to the wound bed for 21 consecutive days or until satisfactory healing.

OTHER

Standard Wound Care

Standard wound care includes saline irrigation, wound debridement, antibiotic administration as necessary, and sterile dressing. Provided to all participants.

Trial Locations (1)

25000

Khyber Teaching Hospital, MTI KTH Peshawar, Peshawar

All Listed Sponsors
lead

Fazeelat Bibi

OTHER

NCT07096830 - Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing | Biotech Hunter | Biotech Hunter